These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Daly PA; Landsberg L Diabetes Care; 1991 Mar; 14(3):240-8. PubMed ID: 2044439 [TBL] [Abstract][Full Text] [Related]
4. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369 [TBL] [Abstract][Full Text] [Related]
6. Factors that influence the risk of hypertension in obese individuals. Coatmellec-Taglioni G; Ribière C Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, energy balance and sympathetic nervous system activity. Landsberg L Clin Exp Hypertens A; 1990; 12(5):817-30. PubMed ID: 2208753 [TBL] [Abstract][Full Text] [Related]
8. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). Landsberg L J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378 [TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Kalil GZ; Haynes WG Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570 [TBL] [Abstract][Full Text] [Related]
11. Obesity-related hypertension: is there a role for selective leptin resistance? Correia ML; Haynes WG Curr Hypertens Rep; 2004 Jun; 6(3):230-5. PubMed ID: 15128477 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and sympathetic effects of leptin. Rahmouni K; Haynes WG; Mark AL Curr Hypertens Rep; 2002 Apr; 4(2):119-25. PubMed ID: 11884267 [TBL] [Abstract][Full Text] [Related]
14. Obesity-hypertension: emerging concepts in pathophysiology and treatment. Mathew B; Patel SB; Reams GP; Freeman RH; Spear RM; Villarreal D Am J Med Sci; 2007 Jul; 334(1):23-30. PubMed ID: 17630587 [TBL] [Abstract][Full Text] [Related]
15. [Hyperleptinemia as a risk factor in obesity-related hypertension]. Alvarez-Aguilar C; Mondragón-Jiménez LI; Ramírez-Enríquez J; Gómez-García A; Paniagua-Sierra R; Amato D Med Clin (Barc); 2004 Dec; 123(20):766-9. PubMed ID: 15607067 [TBL] [Abstract][Full Text] [Related]
16. Sex differences in sympathetic activity in obesity and its related hypertension. Fu Q Ann N Y Acad Sci; 2019 Oct; 1454(1):31-41. PubMed ID: 31087350 [TBL] [Abstract][Full Text] [Related]
17. [Hypertension in obese patients: Pathophysiology and management]. Girerd X; Hansel B Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Krieger DR; Landsberg L Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861 [TBL] [Abstract][Full Text] [Related]
19. Sympathetic activity and body mass index contribute to blood pressure levels. Masuo K; Mikami H; Itoh M; Ogihara T; Tuck ML Hypertens Res; 2000 Jul; 23(4):303-10. PubMed ID: 10912765 [TBL] [Abstract][Full Text] [Related]